Omada Health (OMDA) Stock Price, News & Analysis

Company Overview

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management. The company integrates connected devices—such as smart scales, blood pressure monitors and activity trackers—to monitor participants’ progress and deliver real-time insights. Its multidisciplinary care teams, which include health coaches, registered dietitians and behavioral health specialists, work collaboratively to guide users toward sustainable lifestyle changes and clinical goals.

Founded in 2011 and headquartered in San Francisco, Omada Health partners with a range of stakeholders including employers, health plans and healthcare systems across the United States. Through these partnerships, the company aims to reduce the incidence and costs of chronic disease while improving long-term health outcomes. Co-founder and CEO Sean Duffy leads the organization’s strategic vision, overseeing product development and market expansion initiatives.

Key Stats

• Today's Range: $24.58 to $26.00
• 50-Day Range: $19.02 to $25.41
• 52-Week Range: $14.14 to $28.40
• Volume: 354,275 shs
• Average Volume: 497,528 shs
• Market Capitalization: $1.46 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $25.00
• Consensus Rating: Moderate Buy

OMDA Stock Analysis - Frequently Asked Questions

How have OMDA shares performed this year?

Omada Health's stock was trading at $15.74 at the start of the year. Since then, OMDA stock has increased by 61.4% and is now trading at $25.41.

How were Omada Health's earnings last quarter?

Omada Health, Inc. (NASDAQ:OMDA) posted its earnings results on Thursday, August, 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.07. The business earned $61.37 million during the quarter, compared to analysts' expectations of $55.17 million.
Read the conference call transcript.

When did Omada Health IPO?

Omada Health (OMDA) raised $150 million in an initial public offering on Friday, June 6th 2025. The company issued 7,900,000 shares at $19.00 per share.

When does Omada Health's lock-up period expire?

Omada Health's lock-up period expires on Wednesday, December 3rd. Omada Health had issued 7,900,000 shares in its public offering on June 6th. The total size of the offering was $150,100,000 based on an initial share price of $19.00. After the end of Omada Health's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who are Omada Health's major shareholders?

Top institutional shareholders of Omada Health include Financial Enhancement Group LLC (0.06%) and Inspire Investing LLC (0.04%).

How do I buy shares of Omada Health?

Shares of OMDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/07/2025
• Today: 10/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:OMDA
• Previous Symbol: NASDAQ:OMDA
• CIK: 1611115
• Web: N/A
• Phone: (888) 987-8337
• Fax: N/A
• Employees: 849
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Omada Health: $25.00
• High Price Target: $29.00
• Low Price Target: $19.00
• Potential Upside/Downside: -1.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 57,580,000
• Free Float: N/A
• Market Cap: $1.46 billion
• Optionable: N/A
• Beta: N/A